US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lipocine

8.49

+0.77009.97%

Post-market: 8.490.00000.00%16:10 EST

Volume:120.72K

Turnover:1.02M

Market Cap:47.14M

PE:-8.32

High:8.91

Open:7.84

Low:7.84

Close:7.72

52wk High:12.37

52wk Low:2.52

Shares:5.55M

Float Shares:5.39M

Volume Ratio:1.61

T/O Rate:2.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0204

EPS(LYR):-0.0016

ROE:-32.92%

ROA:-21.45%

PB:3.33

PE(LYR):-5,224.62

Loading ...

Overview Company News Filings

Lipocine Is Maintained at Buy by HC Wainwright & Co.

Lipocine price target raised to $15 from $7 at H.C. Wainwright

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

BRIEF-Lipocine Announces Completion Of Enrollment And Dosing In Phase 3 Trial Of LPCN 1154 In Postpartum Depression

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)

THOMSON REUTERS

Lipocine Inc - Topline Results Expected Early Q2 2026

THOMSON REUTERS

Lipocine updates investor presentation and corporate materials

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned

Lipocine Completes Phase 3 Safety Review of LPCN 1154 for Postpartum Depression

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)

THOMSON REUTERS

Lipocine Inc: on Track to Report Topline Results Early in Q2 of 2026

THOMSON REUTERS

Lipocine Inc - Dsmb Recommends Trial Continue Without Modification

THOMSON REUTERS

Lipocine Nears Full Enrollment in Phase 3 Trial of Oral Brexanolone for Postpartum Depression

Lipocine Director Jeffrey Fink Resigns Effective January 1

Lipocine Q3 EPS USD -0.59

Lipocine Updates Corporate Presentation for Investors

Lipocine Reports Positive Interim Safety Results in Phase 3 Trial of Oral PPD Treatment

Lipocine Inc: Topline Results Are on Track for Q2 of 2026

THOMSON REUTERS

Lipocine Inc: per Drug Safety Monitoring Board (Dsmb) Meeting Evaluating One-Third of Planned Participants, Study to Continue as Planned

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LPCN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LPCN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LPCN\",,,,,undefined,":{"symbol":"LPCN","market":"US","secType":"STK","nameCN":"Lipocine","latestPrice":8.49,"timestamp":1770411600000,"preClose":7.72,"halted":0,"volume":120721,"hourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"16:10 EST","volume":3,"amount":25.47,"timestamp":1770412204875,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.09974093264248711,"floatShares":5394100,"shares":5551931,"eps":-1.020434,"marketStatus":"Market Closed","change":0.77,"latestTime":"02-06 16:00:00 EST","open":7.84,"high":8.91,"low":7.84,"amount":1018920.063607,"amplitude":0.138601,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.020434,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1395374400000,"exchange":"NASDAQ","adjPreClose":7.72,"preHourTrading":{"tag":"盘前","latestPrice":7.9131,"preClose":7.72,"latestTime":"08:37 EST","volume":200,"amount":1582.62,"timestamp":1770385035337,"change":0.1931,"changeRate":0.025013,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":8.49,"preClose":8.49,"latestTime":"16:10 EST","volume":3,"amount":25.47,"timestamp":1770412204875,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6074743186966218,"impliedVol":2.2886,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LPCN\",,,,,undefined,":{"symbol":"LPCN","floatShares":5394100,"roa":"-21.45%","roe":"-32.92%","lyrEps":-0.001625,"volumeRatio":1.6074743186966218,"shares":5551931,"dividePrice":0,"high":8.91,"amplitude":0.138601,"preClose":7.72,"low":7.84,"week52Low":2.52,"pbRate":"3.33","psRate":"10.90","week52High":12.37,"institutionHeld":0,"latestPrice":8.49,"eps":-1.020434,"divideRate":0,"volume":120721,"delay":0,"ttmEps":-1.020434,"open":7.84,"prevYearClose":8.03,"prevWeekClose":9,"prevMonthClose":9,"prevQuarterClose":8.03,"fiveDayClose":9,"twentyDayClose":7.53,"sixtyDayClose":2.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LPCN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"LPCN","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2025-08-05","symbol":"LPCN","fiscalQuarterEnding":"2025/06","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-05-08","symbol":"LPCN","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-13","symbol":"LPCN","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":0.33},{"market":"US","date":"2024-11-07","symbol":"LPCN","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LPCN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LPCN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1748494800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LPCN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LPCN","date":"2026-02-05","current":-8.319989,"percent":0.101043,"low":-257.46841,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"high":2357.436542,"avg":52.737734,"sd":367.434825,"marketCap":45414795},"quantilePoints":[{"date":"2021-02-12","current":-8.626507,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":170335711},{"date":"2021-02-19","current":-7.794509,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":153907393},{"date":"2021-02-26","current":-6.962511,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":137479076},{"date":"2021-03-05","current":-6.261881,"twenty":-4.894079,"median":-3.554414,"eighty":-1.801127,"marketCap":123644704},{"date":"2021-03-12","current":-6.990877,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":146562479},{"date":"2021-03-19","current":-7.032991,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":147445385},{"date":"2021-03-26","current":-6.190717,"twenty":-4.894079,"median":-3.563783,"eighty":-1.805681,"marketCap":129787255},{"date":"2021-04-01","current":-6.527626,"twenty":-4.894079,"median":-3.563783,"eighty":-1.805681,"marketCap":136850507},{"date":"2021-04-09","current":-6.485513,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":135967601},{"date":"2021-04-16","current":-6.148603,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":128904349},{"date":"2021-04-23","current":-6.190717,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":129787255},{"date":"2021-04-30","current":-5.938034,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":124489816},{"date":"2021-05-07","current":-6.611483,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":122724003},{"date":"2021-05-14","current":-6.183402,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":114777845},{"date":"2021-05-21","current":-6.896871,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":128021442},{"date":"2021-05-28","current":-5.802885,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":107714593},{"date":"2021-06-04","current":-5.850449,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":108597499},{"date":"2021-06-11","current":-6.326095,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":117426564},{"date":"2021-06-18","current":-6.468789,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":120075284},{"date":"2021-06-25","current":-7.134694,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":132435975},{"date":"2021-07-02","current":-6.992,"twenty":-4.923396,"median":-3.569952,"eighty":-1.803404,"marketCap":129787255},{"date":"2021-07-09","current":-6.468789,"twenty":-4.964892,"median":-3.575128,"eighty":-1.803404,"marketCap":120075284},{"date":"2021-07-16","current":-5.993143,"twenty":-4.996255,"median":-3.584073,"eighty":-1.803404,"marketCap":111246219},{"date":"2021-07-23","current":-6.278531,"twenty":-5.036066,"median":-3.593536,"eighty":-1.803404,"marketCap":116543658},{"date":"2021-07-30","current":-6.278531,"twenty":-5.082397,"median":-3.593536,"eighty":-1.803404,"marketCap":116543658},{"date":"2021-08-06","current":-6.319201,"twenty":-5.114441,"median":-3.594594,"eighty":-1.803404,"marketCap":120075284},{"date":"2021-08-13","current":-6.737383,"twenty":-5.134595,"median":-3.594594,"eighty":-1.803404,"marketCap":128021442},{"date":"2021-08-20","current":-6.458595,"twenty":-5.249763,"median":-3.594594,"eighty":-1.803404,"marketCap":122724003},{"date":"2021-08-27","current":-6.179807,"twenty":-5.289324,"median":-3.594594,"eighty":-1.803404,"marketCap":117426564},{"date":"2021-09-03","current":-5.808089,"twenty":-5.334785,"median":-3.594594,"eighty":-1.803404,"marketCap":110363312},{"date":"2021-09-10","current":-5.62223,"twenty":-5.383758,"median":-3.594594,"eighty":-1.803404,"marketCap":106831686},{"date":"2021-09-17","current":-5.389906,"twenty":-5.39031,"median":-3.594594,"eighty":-1.803404,"marketCap":102417154},{"date":"2021-09-24","current":-5.111118,"twenty":-5.39031,"median":-3.594594,"eighty":-1.803404,"marketCap":97119715},{"date":"2021-10-01","current":-4.925259,"twenty":-5.39031,"median":-3.594594,"eighty":-1.803404,"marketCap":93588089},{"date":"2021-10-08","current":-4.878795,"twenty":-5.383758,"median":-3.594594,"eighty":-1.803404,"marketCap":92705182},{"date":"2021-10-15","current":-5.250512,"twenty":-5.340243,"median":-3.594594,"eighty":-1.803404,"marketCap":99768434},{"date":"2021-10-22","current":-4.925259,"twenty":-5.350723,"median":-3.594594,"eighty":-1.803404,"marketCap":93588089},{"date":"2021-10-29","current":-4.83233,"twenty":-5.348296,"median":-3.594594,"eighty":-1.805681,"marketCap":91822276},{"date":"2021-11-05","current":-5.204048,"twenty":-5.363631,"median":-3.594594,"eighty":-1.805681,"marketCap":98885528},{"date":"2021-11-12","current":-5.912643,"twenty":-5.415979,"median":-3.594594,"eighty":-1.805681,"marketCap":105065873},{"date":"2021-11-19","current":-5.813271,"twenty":-5.423851,"median":-3.594594,"eighty":-1.805681,"marketCap":103300060},{"date":"2021-11-26","current":-5.614527,"twenty":-5.478962,"median":-3.595816,"eighty":-1.805681,"marketCap":99768434},{"date":"2021-12-03","current":-5.018294,"twenty":-5.478962,"median":-3.601693,"eighty":-1.805681,"marketCap":89173556},{"date":"2021-12-10","current":-5.564841,"twenty":-5.491958,"median":-3.601693,"eighty":-1.805681,"marketCap":98885528},{"date":"2021-12-17","current":-5.415782,"twenty":-5.491958,"median":-3.606179,"eighty":-1.805681,"marketCap":96236808},{"date":"2021-12-23","current":-5.266724,"twenty":-5.491958,"median":-3.606179,"eighty":-1.805681,"marketCap":93588089},{"date":"2021-12-31","current":-4.924387,"twenty":-5.491958,"median":-3.606179,"eighty":-1.805681,"marketCap":87504863},{"date":"2022-01-07","current":-5.117666,"twenty":-5.49044,"median":-3.607985,"eighty":-1.807958,"marketCap":90939369},{"date":"2022-01-14","current":-4.946746,"twenty":-5.49044,"median":-3.62027,"eighty":-1.807958,"marketCap":87902171},{"date":"2022-01-21","current":-4.427526,"twenty":-5.49044,"median":-3.63139,"eighty":-1.807958,"marketCap":78675798},{"date":"2022-01-28","current":-4.828493,"twenty":-5.49044,"median":-3.649414,"eighty":-1.807958,"marketCap":85800853},{"date":"2022-02-04","current":-4.774832,"twenty":-5.49044,"median":-3.649414,"eighty":-1.807958,"marketCap":84847314},{"date":"2022-02-11","current":-5.31641,"twenty":-5.49044,"median":-3.649414,"eighty":-1.807958,"marketCap":94470995},{"date":"2022-02-18","current":-6.21076,"twenty":-5.515155,"median":-3.649414,"eighty":-1.807958,"marketCap":110363312},{"date":"2022-02-25","current":-6.061702,"twenty":-5.529301,"median":-3.649414,"eighty":-1.807958,"marketCap":107714593},{"date":"2022-03-04","current":-7.452912,"twenty":-5.556915,"median":-3.649414,"eighty":-1.807958,"marketCap":132435975},{"date":"2022-03-11","current":-212.933334,"twenty":-5.576022,"median":-3.649414,"eighty":-1.807958,"marketCap":135084694},{"date":"2022-03-18","current":-221.283661,"twenty":-5.600651,"median":-3.649414,"eighty":-1.807958,"marketCap":140382133},{"date":"2022-03-25","current":-257.46841,"twenty":-5.625274,"median":-3.649414,"eighty":-1.807958,"marketCap":163337702},{"date":"2022-04-01","current":-186.490633,"twenty":-5.665109,"median":-3.649414,"eighty":-1.807958,"marketCap":118309471},{"date":"2022-04-08","current":-164.223095,"twenty":-5.717985,"median":-3.649414,"eighty":-1.807958,"marketCap":104182967},{"date":"2022-04-14","current":-147.87044,"twenty":-5.755906,"median":-3.649414,"eighty":-1.807958,"marketCap":93808859},{"date":"2022-04-22","current":-137.714809,"twenty":-5.802885,"median":-3.649414,"eighty":-1.807958,"marketCap":87366137},{"date":"2022-04-29","current":-123.025416,"twenty":-5.811693,"median":-3.649414,"eighty":-1.807958,"marketCap":78047201},{"date":"2022-05-06","current":-113.037186,"twenty":-5.813271,"median":-3.649414,"eighty":-1.807958,"marketCap":71710678},{"date":"2022-05-13","current":-91.186847,"twenty":-5.841119,"median":-3.666486,"eighty":-1.807958,"marketCap":68763819},{"date":"2022-05-20","current":-106.06779,"twenty":-5.853956,"median":-3.691692,"eighty":-1.807958,"marketCap":79985508},{"date":"2022-05-27","current":-100.939263,"twenty":-5.866177,"median":-3.728107,"eighty":-1.807958,"marketCap":76118096},{"date":"2022-06-03","current":-97.81755,"twenty":-5.912643,"median":-3.73964,"eighty":-1.807958,"marketCap":73764019},{"date":"2022-06-10","current":-102.101102,"twenty":-5.945578,"median":-3.768833,"eighty":-1.807958,"marketCap":76994237},{"date":"2022-06-17","current":-94.883611,"twenty":-5.993143,"median":-3.794864,"eighty":-1.807958,"marketCap":71551541},{"date":"2022-06-24","current":-96.397524,"twenty":-6.022262,"median":-3.824312,"eighty":-1.805681,"marketCap":72693180},{"date":"2022-07-01","current":-93.886072,"twenty":-6.04053,"median":-3.832964,"eighty":-1.805681,"marketCap":70799299},{"date":"2022-07-08","current":-91.844049,"twenty":-6.061702,"median":-3.850115,"eighty":-1.805681,"marketCap":69259414},{"date":"2022-07-15","current":-92.747703,"twenty":-6.100131,"median":-3.86568,"eighty":-1.805681,"marketCap":69940857},{"date":"2022-07-22","current":-91.538919,"twenty":-6.131645,"median":-3.86568,"eighty":-1.805681,"marketCap":69029316},{"date":"2022-07-29","current":-88.428943,"twenty":-6.160986,"median":-3.86568,"eighty":-1.805681,"marketCap":66684089},{"date":"2022-08-05","current":-96.573561,"twenty":-6.186328,"median":-3.87803,"eighty":-1.805681,"marketCap":72825929},{"date":"2022-08-12","current":18.241699,"twenty":-6.186328,"median":-3.86568,"eighty":-1.790828,"marketCap":62444363},{"date":"2022-08-19","current":15.767266,"twenty":-6.186328,"median":-3.86568,"eighty":-1.774903,"marketCap":53973968},{"date":"2022-08-26","current":15.113073,"twenty":-6.186328,"median":-3.86568,"eighty":-1.744599,"marketCap":51734557},{"date":"2022-09-02","current":14.735569,"twenty":-6.186328,"median":-3.86568,"eighty":-1.740239,"marketCap":50442299},{"date":"2022-09-09","current":13.310881,"twenty":-6.186328,"median":-3.86568,"eighty":-1.727982,"marketCap":45565355},{"date":"2022-09-16","current":14.660586,"twenty":-6.186328,"median":-3.86568,"eighty":-1.725301,"marketCap":50185618},{"date":"2022-09-23","current":12.837708,"twenty":-6.186328,"median":-3.86568,"eighty":-1.701339,"marketCap":43945607},{"date":"2022-09-30","current":11.635385,"twenty":-6.186328,"median":-3.86568,"eighty":-1.673028,"marketCap":39829855},{"date":"2022-10-07","current":11.764667,"twenty":-6.186328,"median":-3.86568,"eighty":-1.657962,"marketCap":40272409},{"date":"2022-10-14","current":11.635385,"twenty":-6.186328,"median":-3.86568,"eighty":-1.637693,"marketCap":39829855},{"date":"2022-10-21","current":11.410435,"twenty":-6.186328,"median":-3.86568,"eighty":-1.621479,"marketCap":39059812},{"date":"2022-10-28","current":10.66577,"twenty":-6.186328,"median":-3.86568,"eighty":-1.607909,"marketCap":36510701},{"date":"2022-11-04","current":10.233968,"twenty":-6.186328,"median":-3.86568,"eighty":-1.591322,"marketCap":35032571},{"date":"2022-11-11","current":8.245255,"twenty":-6.186328,"median":-3.859558,"eighty":-1.586401,"marketCap":33766778},{"date":"2022-11-18","current":10.376297,"twenty":-6.186328,"median":-3.856954,"eighty":-1.573457,"marketCap":42494030},{"date":"2022-11-25","current":10.300653,"twenty":-6.186328,"median":-3.856954,"eighty":-1.569985,"marketCap":42184242},{"date":"2022-12-02","current":9.730075,"twenty":-6.186328,"median":-3.856954,"eighty":-1.56875,"marketCap":39847558},{"date":"2022-12-09","current":8.759661,"twenty":-6.186328,"median":-3.856954,"eighty":-1.560663,"marketCap":35873423},{"date":"2022-12-16","current":9.185433,"twenty":-6.186328,"median":-3.856954,"eighty":-1.557464,"marketCap":37617086},{"date":"2022-12-23","current":8.768306,"twenty":-6.186328,"median":-3.856954,"eighty":-1.548676,"marketCap":35908827},{"date":"2022-12-30","current":8.597565,"twenty":-6.186328,"median":-3.856954,"eighty":-1.545785,"marketCap":35209592},{"date":"2023-01-06","current":10.371975,"twenty":-6.186328,"median":-3.850115,"eighty":-1.533246,"marketCap":42476328},{"date":"2023-01-13","current":12.02103,"twenty":-6.186328,"median":-3.829635,"eighty":-1.525522,"marketCap":49229701},{"date":"2023-01-20","current":11.670903,"twenty":-6.186328,"median":-3.829635,"eighty":-1.520136,"marketCap":47795827},{"date":"2023-01-27","current":11.554194,"twenty":-6.186328,"median":-3.829635,"eighty":-1.513461,"marketCap":47317868},{"date":"2023-02-03","current":11.887031,"twenty":-6.186328,"median":-3.829635,"eighty":-1.504455,"marketCap":48680935},{"date":"2023-02-10","current":11.433163,"twenty":-6.186328,"median":-3.829635,"eighty":-1.504455,"marketCap":46822208},{"date":"2023-02-17","current":10.806392,"twenty":-6.186328,"median":-3.829635,"eighty":-1.501034,"marketCap":44255395},{"date":"2023-02-24","current":9.302142,"twenty":-6.186328,"median":-3.829635,"eighty":-1.501034,"marketCap":38095044},{"date":"2023-03-03","current":9.496657,"twenty":-6.186328,"median":-3.829635,"eighty":-1.499868,"marketCap":38891641},{"date":"2023-03-10","current":-2.529788,"twenty":-6.186328,"median":-3.829635,"eighty":-1.489742,"marketCap":27217068},{"date":"2023-03-17","current":-2.859689,"twenty":-6.186328,"median":-3.829635,"eighty":-1.492333,"marketCap":30766350},{"date":"2023-03-24","current":-2.446696,"twenty":-6.186328,"median":-3.829635,"eighty":-1.492333,"marketCap":26323109},{"date":"2023-03-31","current":-2.616994,"twenty":-6.184865,"median":-3.827523,"eighty":-1.498706,"marketCap":28155282},{"date":"2023-04-06","current":-2.631802,"twenty":-6.184865,"median":-3.827523,"eighty":-1.498706,"marketCap":28314602},{"date":"2023-04-14","current":-2.459859,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497544,"marketCap":26464726},{"date":"2023-04-21","current":-2.476313,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497544,"marketCap":26641748},{"date":"2023-04-28","current":-2.303547,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497544,"marketCap":24783021},{"date":"2023-05-05","current":-2.053447,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497566,"marketCap":22092293},{"date":"2023-05-12","current":-2.264193,"twenty":-6.186328,"median":-3.829635,"eighty":-1.501087,"marketCap":25225570},{"date":"2023-05-19","current":-1.715085,"twenty":-6.186328,"median":-3.829635,"eighty":-1.525522,"marketCap":19107906},{"date":"2023-05-26","current":-2.434766,"twenty":-6.187791,"median":-3.832756,"eighty":-1.542663,"marketCap":27125937},{"date":"2023-06-02","current":-2.014173,"twenty":-6.187791,"median":-3.832756,"eighty":-1.550008,"marketCap":22440075},{"date":"2023-06-09","current":-2.070252,"twenty":-6.187791,"median":-3.832756,"eighty":-1.557464,"marketCap":23064857},{"date":"2023-06-16","current":-2.350648,"twenty":-6.187791,"median":-3.832756,"eighty":-1.563166,"marketCap":26188765},{"date":"2023-06-23","current":-2.327281,"twenty":-6.189254,"median":-3.835877,"eighty":-1.569999,"marketCap":25928439},{"date":"2023-06-30","current":-2.285222,"twenty":-6.190717,"median":-3.841919,"eighty":-1.589344,"marketCap":25459853},{"date":"2023-07-07","current":-2.010014,"twenty":-6.190717,"median":-3.841919,"eighty":-1.591322,"marketCap":22393737},{"date":"2023-07-14","current":-2.088945,"twenty":-6.190717,"median":-3.841919,"eighty":-1.6107,"marketCap":23273117},{"date":"2023-07-21","current":-2.004827,"twenty":-6.190717,"median":-3.841919,"eighty":-1.668335,"marketCap":22335945},{"date":"2023-07-28","current":-2.38336,"twenty":-6.190717,"median":-3.847962,"eighty":-1.713183,"marketCap":26553221},{"date":"2023-08-04","current":-2.294569,"twenty":-6.190717,"median":-3.847962,"eighty":-1.727826,"marketCap":25563983},{"date":"2023-08-11","current":-2.163275,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":26084635},{"date":"2023-08-18","current":-1.997084,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":24080709},{"date":"2023-08-25","current":-1.816332,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":21901219},{"date":"2023-09-01","current":-1.741386,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":20997528},{"date":"2023-09-08","current":-1.609129,"twenty":-6.190717,"median":-3.847962,"eighty":-1.726955,"marketCap":19402779},{"date":"2023-09-15","current":-1.670849,"twenty":-6.190717,"median":-3.847962,"eighty":-1.697959,"marketCap":20146995},{"date":"2023-09-22","current":-1.450421,"twenty":-6.190717,"median":-3.847962,"eighty":-1.673339,"marketCap":17489080},{"date":"2023-09-29","current":-1.247626,"twenty":-6.190717,"median":-3.847962,"eighty":-1.652504,"marketCap":15043798},{"date":"2023-10-06","current":-1.225583,"twenty":-6.190717,"median":-3.847962,"eighty":-1.608783,"marketCap":14778007},{"date":"2023-10-13","current":-1.221175,"twenty":-6.190717,"median":-3.847962,"eighty":-1.578112,"marketCap":14724849},{"date":"2023-10-20","current":-1.14182,"twenty":-6.190717,"median":-3.847962,"eighty":-1.544351,"marketCap":13767999},{"date":"2023-10-27","current":-1.084509,"twenty":-6.190717,"median":-3.850115,"eighty":-1.533661,"marketCap":13076941},{"date":"2023-11-03","current":-1.137412,"twenty":-6.190717,"median":-3.850115,"eighty":-1.497674,"marketCap":13714841},{"date":"2023-11-10","current":-0.772927,"twenty":-6.190717,"median":-3.850115,"eighty":-1.452788,"marketCap":12598517},{"date":"2023-11-17","current":-0.88055,"twenty":-6.190717,"median":-3.850115,"eighty":-1.374405,"marketCap":14352741},{"date":"2023-11-24","current":-0.815324,"twenty":-6.190717,"median":-3.850115,"eighty":-1.314476,"marketCap":13289575},{"date":"2023-12-01","current":-0.785973,"twenty":-6.190717,"median":-3.850115,"eighty":-1.302121,"marketCap":12811150},{"date":"2023-12-08","current":-0.849013,"twenty":-6.190717,"median":-3.850115,"eighty":-1.287218,"marketCap":13838700},{"date":"2023-12-15","current":-0.834892,"twenty":-6.190717,"median":-3.850115,"eighty":-1.266818,"marketCap":13608524},{"date":"2023-12-22","current":-0.954027,"twenty":-6.190717,"median":-3.850115,"eighty":-1.247626,"marketCap":15550397},{"date":"2023-12-29","current":-0.926208,"twenty":-6.190717,"median":-3.850115,"eighty":-1.24649,"marketCap":15096957},{"date":"2024-01-05","current":-0.968605,"twenty":-6.190717,"median":-3.850115,"eighty":-1.243218,"marketCap":15788015},{"date":"2024-01-12","current":-1.014263,"twenty":-6.190717,"median":-3.850115,"eighty":-1.229992,"marketCap":16532231},{"date":"2024-01-19","current":-1.30778,"twenty":-6.190717,"median":-3.853535,"eighty":-1.22911,"marketCap":21316478},{"date":"2024-01-26","current":-1.249077,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":20359628},{"date":"2024-02-02","current":-1.297996,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":21157003},{"date":"2024-02-09","current":-1.30778,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":21316478},{"date":"2024-02-16","current":-1.30778,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":21316478},{"date":"2024-02-23","current":-1.271906,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":20731737},{"date":"2024-03-01","current":-1.242554,"twenty":-6.190717,"median":-3.850115,"eighty":-1.226368,"marketCap":20253312},{"date":"2024-03-08","current":-1.180061,"twenty":-6.190717,"median":-3.841919,"eighty":-1.22267,"marketCap":19296462},{"date":"2024-03-15","current":-1.524652,"twenty":-6.190717,"median":-3.820107,"eighty":-1.219441,"marketCap":24931242},{"date":"2024-03-22","current":-1.336103,"twenty":-6.190717,"median":-3.777296,"eighty":-1.219441,"marketCap":21848061},{"date":"2024-03-28","current":-1.6673,"twenty":-6.190717,"median":-3.515893,"eighty":-1.219441,"marketCap":27263828},{"date":"2024-04-05","current":-1.498646,"twenty":-6.190717,"median":-3.447774,"eighty":-1.219007,"marketCap":24505976},{"date":"2024-04-12","current":-2.0838,"twenty":-6.190717,"median":-3.399569,"eighty":-1.219007,"marketCap":34074470},{"date":"2024-04-19","current":-1.768467,"twenty":-6.190717,"median":-3.352097,"eighty":-1.219007,"marketCap":28918115},{"date":"2024-04-26","current":-1.47914,"twenty":-6.190717,"median":-3.325493,"eighty":-1.219441,"marketCap":24187026},{"date":"2024-05-03","current":-1.537133,"twenty":-6.190717,"median":-3.296372,"eighty":-1.219441,"marketCap":25135318},{"date":"2024-05-10","current":-3.124719,"twenty":-6.190717,"median":-3.245681,"eighty":-1.219441,"marketCap":28023205},{"date":"2024-05-17","current":-3.428843,"twenty":-6.190717,"median":-3.236813,"eighty":-1.219441,"marketCap":30750655},{"date":"2024-05-24","current":-3.899936,"twenty":-6.190717,"median":-3.281153,"eighty":-1.219441,"marketCap":34975527},{"date":"2024-05-31","current":-4.126538,"twenty":-6.190717,"median":-3.333973,"eighty":-1.219441,"marketCap":37007744},{"date":"2024-06-07","current":-4.48433,"twenty":-6.190717,"median":-3.352097,"eighty":-1.219441,"marketCap":40216508},{"date":"2024-06-14","current":-5.659081,"twenty":-6.190717,"median":-3.423041,"eighty":-1.219441,"marketCap":50751950},{"date":"2024-06-21","current":-5.354958,"twenty":-6.190717,"median":-3.458513,"eighty":-1.219007,"marketCap":48024501},{"date":"2024-06-28","current":-4.913681,"twenty":-6.190717,"median":-3.601693,"eighty":-1.219007,"marketCap":44067025},{"date":"2024-07-05","current":-4.347176,"twenty":-6.190717,"median":-3.798562,"eighty":-1.219007,"marketCap":38986482},{"date":"2024-07-12","current":-4.585705,"twenty":-6.190717,"median":-3.86568,"eighty":-1.219007,"marketCap":41125658},{"date":"2024-07-19","current":-3.369211,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":30215861},{"date":"2024-07-26","current":-3.285726,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":29467149},{"date":"2024-08-02","current":-2.95775,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":26525782},{"date":"2024-08-09","current":-2.778482,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":23584415},{"date":"2024-08-16","current":-2.331153,"twenty":-6.190717,"median":-3.822414,"eighty":-1.219007,"marketCap":19787378},{"date":"2024-08-23","current":-2.312252,"twenty":-6.190717,"median":-3.774709,"eighty":-1.219007,"marketCap":19626939},{"date":"2024-08-30","current":-2.312252,"twenty":-6.190717,"median":-3.509342,"eighty":-1.219007,"marketCap":19626939},{"date":"2024-09-06","current":-2.305951,"twenty":-6.183402,"median":-3.428843,"eighty":-1.219007,"marketCap":19573460},{"date":"2024-09-13","current":-2.904491,"twenty":-6.179807,"median":-3.285726,"eighty":-1.219007,"marketCap":24654003},{"date":"2024-09-20","current":-3.0494,"twenty":-6.179807,"median":-3.135292,"eighty":-1.219007,"marketCap":25884029},{"date":"2024-09-27","current":-2.797384,"twenty":-6.179807,"median":-3.0494,"eighty":-1.219007,"marketCap":23744853},{"date":"2024-10-04","current":-2.935993,"twenty":-6.179807,"median":-3.005455,"eighty":-1.219007,"marketCap":24921400},{"date":"2024-10-11","current":-3.238413,"twenty":-6.179807,"median":-3.005455,"eighty":-1.219007,"marketCap":27488411},{"date":"2024-10-18","current":-3.295116,"twenty":-6.160927,"median":-3.005455,"eighty":-1.219007,"marketCap":27969726},{"date":"2024-10-25","current":-3.635339,"twenty":-6.135837,"median":-3.005455,"eighty":-1.219007,"marketCap":30857613},{"date":"2024-11-01","current":-3.830652,"twenty":-6.135837,"median":-3.005455,"eighty":-1.219007,"marketCap":32515475},{"date":"2024-11-08","current":-6.276052,"twenty":-6.161074,"median":-3.005455,"eighty":-1.219007,"marketCap":25456194},{"date":"2024-11-15","current":-6.447457,"twenty":-6.190717,"median":-3.047586,"eighty":-1.221175,"marketCap":26151426},{"date":"2024-11-22","current":-6.790266,"twenty":-6.210127,"median":-3.124719,"eighty":-1.225583,"marketCap":27541891},{"date":"2024-11-29","current":-5.985982,"twenty":-6.21076,"median":-3.156507,"eighty":-1.230089,"marketCap":24279647},{"date":"2024-12-06","current":-6.724342,"twenty":-6.230966,"median":-3.20061,"eighty":-1.243218,"marketCap":27274494},{"date":"2024-12-13","current":-6.618861,"twenty":-6.272736,"median":-3.285726,"eighty":-1.246712,"marketCap":26846658},{"date":"2024-12-20","current":-6.421087,"twenty":-6.276052,"median":-3.351321,"eighty":-1.249077,"marketCap":26044467},{"date":"2024-12-27","current":-6.276052,"twenty":-6.278531,"median":-3.447774,"eighty":-1.258071,"marketCap":25456194},{"date":"2025-01-03","current":-6.671601,"twenty":-6.278531,"median":-3.470585,"eighty":-1.260287,"marketCap":27060576},{"date":"2025-01-10","current":-6.447457,"twenty":-6.32058,"median":-3.509336,"eighty":-1.269051,"marketCap":26151426},{"date":"2025-01-17","current":-5.761838,"twenty":-6.32058,"median":-3.602806,"eighty":-1.276131,"marketCap":23370497},{"date":"2025-01-24","current":-6.183757,"twenty":-6.32058,"median":-3.780552,"eighty":-1.276131,"marketCap":25081838},{"date":"2025-01-31","current":-5.695913,"twenty":-6.32058,"median":-3.820233,"eighty":-1.28169,"marketCap":23103100},{"date":"2025-02-07","current":-4.614744,"twenty":-6.32058,"median":-3.889341,"eighty":-1.286942,"marketCap":18717790},{"date":"2025-02-14","current":-4.786149,"twenty":-6.32058,"median":-3.962351,"eighty":-1.297621,"marketCap":19413022},{"date":"2025-02-21","current":-4.456524,"twenty":-6.32058,"median":-4.104421,"eighty":-1.297996,"marketCap":18076037},{"date":"2025-02-28","current":-4.04779,"twenty":-6.32058,"median":-4.125777,"eighty":-1.303214,"marketCap":16418175},{"date":"2025-03-07","current":-4.535634,"twenty":-6.321959,"median":-4.15327,"eighty":-1.30191,"marketCap":18396913},{"date":"2025-03-14","current":2146.03592,"twenty":-6.321959,"median":-4.155799,"eighty":-1.297246,"marketCap":17923692},{"date":"2025-03-21","current":2267.751437,"twenty":-6.321959,"median":-4.155799,"eighty":-1.292126,"marketCap":18940260},{"date":"2025-03-28","current":2101.193367,"twenty":-6.321959,"median":-4.155799,"eighty":-1.283647,"marketCap":17549167},{"date":"2025-04-04","current":1928.229286,"twenty":-6.321959,"median":-4.155799,"eighty":-1.270601,"marketCap":16104571},{"date":"2025-04-11","current":1966.665709,"twenty":-6.32058,"median":-4.155799,"eighty":-1.258861,"marketCap":16425592},{"date":"2025-04-17","current":1921.823276,"twenty":-6.32058,"median":-4.155799,"eighty":-1.254295,"marketCap":16051068},{"date":"2025-04-25","current":2043.538673,"twenty":-6.321959,"median":-4.155799,"eighty":-1.243218,"marketCap":17067635},{"date":"2025-05-02","current":2139.629909,"twenty":-6.321959,"median":-4.155799,"eighty":-1.229799,"marketCap":17870189},{"date":"2025-05-09","current":-3.262933,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":17522415},{"date":"2025-05-16","current":-3.975299,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":21347920},{"date":"2025-05-23","current":-3.676404,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":19742813},{"date":"2025-05-30","current":-3.332675,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":17896940},{"date":"2025-06-06","current":-3.110497,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":16703811},{"date":"2025-06-13","current":-3.148357,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":16907124},{"date":"2025-06-20","current":-3.193191,"twenty":-6.323337,"median":-4.161127,"eighty":-1.222938,"marketCap":17147890},{"date":"2025-06-27","current":-3.208136,"twenty":-6.323337,"median":-4.161127,"eighty":-1.222938,"marketCap":17228146},{"date":"2025-07-03","current":-3.088578,"twenty":-6.323337,"median":-4.161127,"eighty":-1.222938,"marketCap":16586103},{"date":"2025-07-11","current":-3.307767,"twenty":-6.323337,"median":-4.142886,"eighty":-1.222938,"marketCap":17763181},{"date":"2025-07-18","current":-3.15832,"twenty":-6.323337,"median":-4.142886,"eighty":-1.222938,"marketCap":16960628},{"date":"2025-07-25","current":-3.307767,"twenty":-6.323337,"median":-4.100978,"eighty":-1.222938,"marketCap":17763181},{"date":"2025-08-01","current":-3.218099,"twenty":-6.323337,"median":-3.961143,"eighty":-1.222938,"marketCap":17281649},{"date":"2025-08-08","current":-3.582862,"twenty":-6.315296,"median":-3.868444,"eighty":-1.222938,"marketCap":16148760},{"date":"2025-08-15","current":-3.655,"twenty":-6.278531,"median":-3.801544,"eighty":-1.222938,"marketCap":16473902},{"date":"2025-08-22","current":-3.618931,"twenty":-6.275609,"median":-3.676404,"eighty":-1.222938,"marketCap":16311331},{"date":"2025-08-29","current":-3.582862,"twenty":-6.274061,"median":-3.655,"eighty":-1.222938,"marketCap":16148760},{"date":"2025-09-05","current":-3.474654,"twenty":-6.274502,"median":-3.630954,"eighty":-1.222057,"marketCap":15661045},{"date":"2025-09-12","current":-3.53477,"twenty":-6.274061,"median":-3.618931,"eighty":-1.222938,"marketCap":15931998},{"date":"2025-09-19","current":-3.37847,"twenty":-6.274061,"median":-3.602806,"eighty":-1.222938,"marketCap":15227522},{"date":"2025-09-26","current":-3.222171,"twenty":-6.274061,"median":-3.570839,"eighty":-1.222938,"marketCap":14523045},{"date":"2025-10-03","current":-3.715115,"twenty":-6.274061,"median":-3.553462,"eighty":-1.222938,"marketCap":16744855},{"date":"2025-10-10","current":-3.787253,"twenty":-6.274061,"median":-3.553462,"eighty":-1.222938,"marketCap":17069998},{"date":"2025-10-17","current":-3.739161,"twenty":-6.274061,"median":-3.553462,"eighty":-1.222938,"marketCap":16853236},{"date":"2025-10-24","current":-3.354424,"twenty":-6.274061,"median":-3.528758,"eighty":-1.222938,"marketCap":15119141},{"date":"2025-10-31","current":-3.125987,"twenty":-6.274061,"median":-3.505031,"eighty":-1.222938,"marketCap":14089522},{"date":"2025-11-07","current":-3.174079,"twenty":-6.274061,"median":-3.488553,"eighty":-1.222938,"marketCap":14306284},{"date":"2025-11-14","current":-2.8595,"twenty":-6.274061,"median":-3.472619,"eighty":-1.222938,"marketCap":15656445},{"date":"2025-11-21","current":-3.194123,"twenty":-6.274061,"median":-3.441591,"eighty":-1.222938,"marketCap":17488582},{"date":"2025-11-28","current":-3.488185,"twenty":-6.274061,"median":-3.427335,"eighty":-1.222938,"marketCap":19098642},{"date":"2025-12-05","current":-3.143422,"twenty":-6.274061,"median":-3.402659,"eighty":-1.222938,"marketCap":17210986},{"date":"2025-12-12","current":-3.224543,"twenty":-6.274061,"median":-3.37847,"eighty":-1.222938,"marketCap":17655140},{"date":"2025-12-19","current":-4.25883,"twenty":-6.274061,"median":-3.362565,"eighty":-1.222938,"marketCap":23318110},{"date":"2025-12-26","current":-4.715134,"twenty":-6.274061,"median":-3.362565,"eighty":-1.222938,"marketCap":25816479},{"date":"2026-01-02","current":-8.142478,"twenty":-6.276052,"median":-3.362565,"eighty":-1.222938,"marketCap":44582005},{"date":"2026-01-09","current":-7.635474,"twenty":-6.278531,"median":-3.362565,"eighty":-1.222938,"marketCap":41806040},{"date":"2026-01-16","current":-11.417722,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":62514743},{"date":"2026-01-23","current":-10.591306,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":57989919},{"date":"2026-01-30","current":-9.115925,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":49911859},{"date":"2026-02-05","current":-8.294579,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":45414795}],"updateTime":1770434560478},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LPCN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605096781","title":"Lipocine Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2605096781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605096781?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:41","pubTimestamp":1768995660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LPCN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2026 06:41 ET (11:41 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN"],"gpt_icon":0},{"id":"2605172106","title":"Lipocine price target raised to $15 from $7 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2605172106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605172106?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:15","pubTimestamp":1768994146,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Lipocine (LPCN) to $15 from $7 and keeps a Buy rating on the shares. The firm says LPCN 1154 show...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lipocine-price-target-raised-to-15-from-7-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lipocine-price-target-raised-to-15-from-7-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN"],"gpt_icon":0},{"id":"2604114121","title":"Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2604114121","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604114121?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:59","pubTimestamp":1768921148,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) has shared an announcement. On January 20, 2026, Lipocine announced it has completed enrollment and dosing of 90 patients in i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-completes-phase-3-enrollment-for-postpartum-depression-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-completes-phase-3-enrollment-for-postpartum-depression-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2604132501","title":"BRIEF-Lipocine Announces Completion Of Enrollment And Dosing In Phase 3 Trial Of LPCN 1154 In Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2604132501","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604132501?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:02","pubTimestamp":1768914147,"startTime":"0","endTime":"0","summary":"BRIEF-Lipocine Announces Completion Of Enrollment And Dosing In Phase 3 Trial Of LPCN 1154 In Postpartum DepressionJan 20 (Reuters) - Lipocine Inc LPCN.O:LIPOCINE ANNOUNCES COMPLETION OF ENROLLMENT AN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA5NH1ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2604113997","title":"Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113997?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:00","pubTimestamp":1768914006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA5NH1ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2604113919","title":"Lipocine Inc - Topline Results Expected Early Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113919?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:00","pubTimestamp":1768914006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA5NH1ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2603529135","title":"Lipocine updates investor presentation and corporate materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2603529135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603529135?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:48","pubTimestamp":1768254510,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) has shared an announcement. Lipocine reported that it has updated the corporate presentation it uses in discussions with inves...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-investor-presentation-and-corporate-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-investor-presentation-and-corporate-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4588","BK4007","BK4544","BK4585","LPCN"],"gpt_icon":0},{"id":"2602541332","title":"Lipocine Advances Phase 3 Postpartum Depression Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541332","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602541332?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:01","pubTimestamp":1768230116,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Lipocine ( ($LPCN) ). On January 12, 2026, Lipocine reported that an independent Data Safety Monitoring Board c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-advances-phase-3-postpartum-depression-drug-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-advances-phase-3-postpartum-depression-drug-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2602951079","title":"Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2602951079","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602951079?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:16","pubTimestamp":1768223784,"startTime":"0","endTime":"0","summary":"Lipocine (LPCN) announced the completion of a scheduled independent Data Safety Monitoring Board review of its ongoing Phase 3 clinical trial evalu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lipocine-dsmb-recommended-phase-3-lpcn-1154-continue-as-planned-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lipocine-dsmb-recommended-phase-3-lpcn-1154-continue-as-planned-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2602569510","title":"Lipocine Completes Phase 3 Safety Review of LPCN 1154 for Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2602569510","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602569510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:03","pubTimestamp":1768223022,"startTime":"0","endTime":"0","summary":"Lipocine Inc. has announced the completion of the second scheduled independent Data Safety Monitoring Board  review for its ongoing Phase 3 clinical trial evaluating LPCN 1154, an oral formulation of brexanolone, for the rapid relief treatment of postpartum depression . The DSMB assessed all available safety data from 82 randomized participants, with 74 having completed dosing, and recommended the trial continue as planned without modification. No drug discontinuations, excessive sedation, loss of consciousness, or drug-related serious adverse events have been reported. The company is no longer screening new participants but continues to enroll those who have already met eligibility criteria. Lipocine expects to report topline safety and efficacy results from the study early in the second quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8QvdcB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2602774517","title":"Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602774517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602774517?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA3HBTSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2602517084","title":"Lipocine Inc: on Track to Report Topline Results Early in Q2 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517084?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA3HBTSX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2602251777","title":"Lipocine Inc - Dsmb Recommends Trial Continue Without Modification","url":"https://stock-news.laohu8.com/highlight/detail?id=2602251777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602251777?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA3HBTSX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2591816982","title":"Lipocine Nears Full Enrollment in Phase 3 Trial of Oral Brexanolone for Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2591816982","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591816982?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:03","pubTimestamp":1765890239,"startTime":"0","endTime":"0","summary":"Lipocine Inc. announced that its Phase 3 clinical trial evaluating LPCN 1154  for the rapid relief treatment of postpartum depression has reached 80% enrollment, with 66 of the planned 80 participants randomized. The company also stated that the second independent Data Safety Monitoring Board review is scheduled for mid-January 2026. Topline results from the study are expected to be available in the second quarter of 2026. No results from the study have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via PR Newswire  on December 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL1rtx6G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2591090621","title":"Lipocine Director Jeffrey Fink Resigns Effective January 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2591090621","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591090621?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:06","pubTimestamp":1765832784,"startTime":"0","endTime":"0","summary":"Lipocine Inc. announced that Jeffrey Fink will resign from its Board of Directors effective January 1, 2026, citing personal reasons. The company plans to begin searching for a new director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL3pkwYc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2584926797","title":"Lipocine Q3 EPS USD -0.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2584926797","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584926797?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:54","pubTimestamp":1763571274,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Lipocine Q3 basic EPS USD -0.59.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202512:32:33.287 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDnM4td:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2584683956","title":"Lipocine Updates Corporate Presentation for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2584683956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584683956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:58","pubTimestamp":1763477907,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) just unveiled an update. Lipocine has updated its corporate presentation, which is used for meetings with investors and analys...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-corporate-presentation-for-investors-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-corporate-presentation-for-investors-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4211","ISBC","LPCN"],"gpt_icon":0},{"id":"2584250937","title":"Lipocine Reports Positive Interim Safety Results in Phase 3 Trial of Oral PPD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584250937","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584250937?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:03","pubTimestamp":1763470984,"startTime":"0","endTime":"0","summary":"Lipocine Inc. announced the completion of a scheduled independent Data Safety Monitoring Board  review for its ongoing Phase 3 clinical trial evaluating LPCN 1154, an oral brexanolone product candidate for the rapid relief of postpartum depression . The DSMB recommended that the trial continue as planned without modification after reviewing safety data from approximately one-third of the planned 80 participants. To date, 47 participants have completed dosing with no reported drug-related serious adverse events, dose reductions, discontinuations, excessive sedation, or loss of consciousness. Topline results from the Phase 3 study are expected in the second quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. pub","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL1D001w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2584937926","title":"Lipocine Inc: Topline Results Are on Track for Q2 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584937926?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:00","pubTimestamp":1763470837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA7QQ28F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2584937467","title":"Lipocine Inc: per Drug Safety Monitoring Board (Dsmb) Meeting Evaluating One-Third of Planned Participants, Study to Continue as Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584937467?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:00","pubTimestamp":1763470837,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA7QQ28F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}